Schmidt U - Search Results

1

Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.

Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A, Wirth MP. Fuessel S, et al. Among authors: schmidt u. Int J Oncol. 2003 Jul;23(1):221-8. Int J Oncol. 2003. PMID: 12792797

2

Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.

Schmidt U, Bilkenroth U, Linné C, Fuessel S, Kraemer K, Froehner M, Wirth MP, Meye A. Schmidt U, et al. Int J Oncol. 2004 Jun;24(6):1393-9. Int J Oncol. 2004. PMID: 15138579

3

Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.

Hoefling C, Schmidt H, Meinhardt M, Lohse A, Taubert H, Fuessel S, Schmidt U, Schuster K, Baretton G, Wirth MP, Meye A. Hoefling C, et al. Among authors: schmidt u, schmidt h. Int J Mol Med. 2004 Jun;13(6):835-42. Int J Mol Med. 2004. PMID: 15138621

4

siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.

Ning S, Fuessel S, Kotzsch M, Kraemer K, Kappler M, Schmidt U, Taubert H, Wirth MP, Meye A. Ning S, et al. Among authors: schmidt u. Int J Oncol. 2004 Oct;25(4):1065-71. Int J Oncol. 2004. PMID: 15375557

5

Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignancies.

Schmidt U, Fuessel S, Haase M, Kraemer K, Meye A, Wirth MP. Schmidt U, et al. Cancer Lett. 2005 Jul 28;225(2):253-60. doi: 10.1016/j.canlet.2004.10.037. Epub 2004 Dec 9. Cancer Lett. 2005. PMID: 15978328

6

Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs.

Fuessel S, Weigle B, Schmidt U, Baretton G, Koch R, Bachmann M, Rieber EP, Wirth MP, Meye A. Fuessel S, et al. Among authors: schmidt u. Cancer Lett. 2006 May 8;236(1):95-104. doi: 10.1016/j.canlet.2005.05.005. Epub 2005 Jun 27. Cancer Lett. 2006. PMID: 15979782

7

Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.

Kraemer K, Schmidt U, Fuessel S, Herr A, Wirth MP, Meye A. Kraemer K, et al. Among authors: schmidt u. Int J Cancer. 2006 Sep 15;119(6):1276-84. doi: 10.1002/ijc.21975. Int J Cancer. 2006. PMID: 16615118

8

Functional analyses of C13orf19/P38IP in prostate cell lines.

Kunze D, Fuessel S, Meye A, Wirth MP, Schmidt U. Kunze D, et al. Among authors: schmidt u. Oncol Rep. 2006 Jun;15(6):1599-604. Oncol Rep. 2006. PMID: 16685401

9

Quantitative multi-gene expression profiling of primary prostate cancer.

Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S, Unversucht S, Froehner M, Wirth MP, Meye A. Schmidt U, et al. Prostate. 2006 Oct 1;66(14):1521-34. doi: 10.1002/pros.20490. Prostate. 2006. PMID: 16921506

10

Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.

Schindler A, Fiedler U, Meye A, Schmidt U, Füssel S, Pilarsky C, Herrmann J, Wirth MP. Schindler A, et al. Among authors: schmidt u. Int J Oncol. 2001 Jul;19(1):25-30. Int J Oncol. 2001. PMID: 11408918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,766 results

Search Page

Filters